UNSPSC 41171502: Antimicrobial susceptibility test powder

In this classification an antimicrobial susceptibility test powder is a device that consists of an antimicrobial drug powder packaged in vials in specified amounts and intended for use in clinical laboratories for determining in vitro susceptibility of bacterial pathogens to these therapeutic agents. Test results are used to determine the antimicrobial agent of choice in the treatment of bacterial diseases US FDA regulates Antimicrobial susceptibility test powder under 21 CFR 866.1640 and under FDA product code MJA.

UNSPSC 41171502 Antimicrobial susceptibility test powder is a Commodity code covering laboratory reagents used to test bacterial resistance to antibiotics and other antimicrobial agents. State and local health departments, public health laboratories, and hospital systems procure these powders to support diagnostic microbiology operations—determining which antimicrobials are effective against cultured pathogens to guide clinical treatment decisions. The work involves supplying standardized, quality-controlled powder formulations that meet clinical laboratory standards (such as CLSI protocols) and regulatory requirements for accuracy and traceability.

The source provides no recent state and local procurement opportunities under this code. Without posted solicitations identifying issuing bodies, geographic activity, or representative RFP or IFB notices, no characterization of current market demand or buyer concentration is supported.